Skip to Main Content

Author Details

Christos Markopoulos
National and Kapodistrian University of Athens
1987
173
33
PMIDPaper TitleJournal TitlePublished Year
36928723Correction: The Role of Attachment Styles on Quality of Life and Distress Among Early-Stage Female Breast Cancer Patients: A Systematic Review.J Clin Psychol Med Settings2023
37643779Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.Cancer Genomics Proteomics2023
34949660Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients.Cancer Genomics Proteomics2022
35610366Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.Br J Cancer2022
35526835Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.J Mol Diagn2022
34238931Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.NPJ Breast Cancer2021
33893081Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer.Cancer Genomics Proteomics2021
32146094The challenge of avoiding over- and under-treatment in older women with ductal cancer in situ: A scoping review of existing knowledge gaps and a meta-analysis of real-world practice patterns.J Geriatr Oncol2020
32075718Theoretical and practical knowledge curriculum for European Breast Surgeons.Eur J Surg Oncol2020
31706719Multigene assays in early breast cancer: Insights from recent phase 3 studies.Eur J Surg Oncol2020
32706636Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials.J Clin Oncol2020
32303794Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?Cancer Immunol Immunother2020
31159747Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.BMC Cancer2019
31933581European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes.Breast Care (Basel)2019
31933578Towards Harmonisation of Breast Care in Europe.Breast Care (Basel)2019
29174281Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data.Eur J Surg Oncol2018
29917140Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.J Natl Cancer Inst2018
29885375Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial.Eur J Cancer2018
30063723Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.PLoS One2018
30420699Pathway-based subnetworks enable cross-disease biomarker discovery.Nat Commun2018
29310832Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.Cancer Genet2018
27639633Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information?Eur J Surg Oncol2017
28441617The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value?Breast2017
28649643Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.NPJ Breast Cancer2017
28666187Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.Transl Oncol2017
28551632The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.Anticancer Res2017
28732650Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.Lancet Oncol2017
28602710Controversial issues in the management of older adults with early breast cancer.J Geriatr Oncol2017
26970928Screening mammography: Usefulness beyond early detection of breast cancer.Atherosclerosis2016
29894075Incidence of inactive allele CYP2D6*4 among Greek women suffering from hormone-sensitive breast cancer.Eur J Gynaecol Oncol2016
27117158The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.Breast Cancer Res Treat2016
27446480White blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma.Oncol Lett2016
27369359Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.Breast Cancer Res Treat2016
27212697Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons.Breast2016
26717057Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial.Arch Pathol Lab Med2016
26681681Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.Ann Oncol2016
25591836Does patient education work in breast cancer? Final results from the global CARIATIDE study.Future Oncol2015
26610383A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.Adv Ther2015
26284903Combination of Calcium Hydroxyapatite Antibiotic Carrier with Cement Spacers in Peri-Prosthetic Knee Infections.Surg Infect (Larchmt)2015
25963429Surgery for liver metastases from breast cancer.Future Oncol2015
25767734Inflammatory myofibroblastic tumor of the breast.Case Rep Surg2015
24184673Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.Eur J Pharm Biopharm2014
25314051Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.Br J Cancer2014
25071141Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study.J Clin Oncol2014
25026897Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.BMC Cancer2014
25114852Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen.World J Clin Oncol2014
24949917The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes.Anticancer Drugs2014
24675394The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.Breast2014
24475110A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon.PLoS One2014
24158740When and how to operate on thoracic and lumbar spine fractures?Eur J Orthop Surg Traumatol2014
  • 1 - 50 of 173

Recommended Authors

Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 6
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 7
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 9
Division of Biostatistics and Clinical Trials, Mayo Clinic
Career Start Year 2003
Number of shared co-authors 2
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 6
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 3
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 10
Universite Libre de Bruxelles
Career Start Year 2000
Number of shared co-authors 3
University of California
Career Start Year 1996
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 0
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 1
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 2
University Health Network
Career Start Year 1992
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 7
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 8
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 9
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 1
University of Bern
Career Start Year 1985
Number of shared co-authors 7
Universita degli Studi di Milano
Career Start Year 1984
Number of shared co-authors 0
University of Toronto, University Health Network
Career Start Year 1984
Number of shared co-authors 2
University of Queensland
Career Start Year 1983
Number of shared co-authors 6
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1976
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1976
Number of shared co-authors 4
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 9
Mayo Clinic
Career Start Year 1952
Number of shared co-authors 1

Collaborators

Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 24
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 22
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 21
Erasmus Medical Center
Co-authored papers 21
University of Edinburgh
Co-authored papers 16
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 14
Helios Medical Centre
Co-authored papers 10
University of Edinburgh
Co-authored papers 7
Leicester Clinical Trials Unit, University of Leicester
Co-authored papers 6
Queen Elizabeth University Hospital
Co-authored papers 5
UPMC Hillman Cancer Center
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Ontario Institute of Cancer Research, MaRS Institute
Co-authored papers 3
University of Guelph
Co-authored papers 2
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 2
MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
Co-authored papers 2
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Co-authored papers 2
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Institute of Cancer Research
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Sahlgrenska University Hospital
Co-authored papers 1
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 1